Effects of blood pressure lowering and metabolic control on systolic left ventricular function in Type II diabetes mellitus

Clinical Science

Volumn 111, Issue 1, 2006, Pages 53-59

  Andersen, Niels H ^a   Poulsen, Steen H ^a   Poulsen, Per L ^a   Knudsen, Søren T ^a   Helleberg, Kjeld ^b   Hansen, Klavs W ^c   Dinesen, Dines S ^a   Eiskjær, Hans ^a   Flyvbjerg, Allan ^a   Mogensen, Carl E ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b VIBORG HOSPITAL   (Denmark)

^c SILKEBORG REGIONAL HOSPITAL   (Denmark)

Author keywords

Cardiomyopathy; Congestive heart failure; Hyperglycaemia; Hypertension; Systole; Type II diabetes; Ventricular function

Indexed keywords

CANDESARTAN; CANDESARTAN HEXETIL; FRUCTOSAMINE; HEMOGLOBIN A1C; LISINOPRIL;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE DURATION; DOPPLER ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; FRUCTOSAMINE BLOOD LEVEL; GLYCEMIC CONTROL; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE MASS; HUMAN; HYPERTENSION; MALE; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

AGED; ANTIHYPERTENSIVE AGENTS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; FOLLOW-UP STUDIES; FRUCTOSAMINE; HEART VENTRICLES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; ORGAN SIZE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 33745780533     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20050367     Document Type: Article

References (30)

1. Nichols, G. A., Gullion, C. M., Koro, C. E., Ephross, S. A. and Brown, J. B. (2004) The incidence of congestive heart failure in type 2 diabetes: an update. Diabetes Care 27, 1879-1984
2. Gustafsson, I., Brendorp, B., Seibaek, M. et al. (2004) Influence of diabetes and diabetes-gender interaction on the risk of death in patients hospitalized with congestive heart failure. J. Am. Coll. Cardiol. 43, 771-777
3. Andersen, N. H., Poulsen, S. H., Eiskjaer, H., Poulsen, P. L. and Mogensen, C. E. (2003) Decreased left ventricular longitudinal contraction in normotensive and normoalbuminuric patients with Type II diabetes mellitus: a doppler tissue tracking and strain rate echocardiography study. Clin. Sci. 105, 59-66
4. Poirier, P., Bogaty, P., Garneau, C., Marois, L. and Dumesnil, J. G. (2001) Diastolic dysfunction in normotensive men with well-controlled type 2 diabetes: importance of maneuvers in echocardiographic screening for preclinical diabetic cardiomyopathy. Diabetes Care 24, 5-10
5. Zabalgoitia, M., Ismaeil, M. F., Anderson, L. and Maklady, F. A. (2001) Prevalence of diastolic dysfunction in normotensive, asymptomatic patients with well-controlled type 2 diabetes mellitus. Am. J. Cardiol. 87, 320-323
6. Fang, Z. Y., Yuda, S., Anderson, V., Short, L., Case, C. and Marwick, T. U. (2003) Echocardiographic detection of early diabetic myocardial disease. J. Am. Coll. Cardiol. 41, 611-617
7. Vinereanu, D., Nicolaides, E., Tweddel, A. C. et al. (2003) Subclinical left ventricular dysfunction in asymptomatic patients with Type II diabetes mellitus, related to serum lipids and glycated haemoglobin. Clin. Sci. 105, 591-599
8. Andersen, N. H., Poulsen, S, H., Poulsen, P. L. et al. (2005) Left ventricular dysfunction in hypertensive patients with type 2 diabetes mellitus. Diabetic Med. 22, 1218-1225
9. Fang, Z. Y., Schull-Meade, R., Downey, M., Prins, J. and Marwick, T. H. (2005) Determinants of subclinical diabetic heart disease. Diabetologia 48, 394-402
10. Candido, R., Forbes, J. M., Thomas, M. C. et al. (2003) A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changes. Circ. Res. 92, 785-792
11. Andersen, N. H., Poulsen, P. L., Knudsen, S. T. et al. (2005) Long-term dual blockade with candesartan and lisinopril in hypertensive patients with diabetes: The CALM II study. Diabetes Care 28, 273-277
12. Schiller, N. B., Shah, P. M., Crawford, M. et al. (1989) Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J. Am. Soc. Ekhocardiogr. 2, 358-367
13. de Simone, G., Devereux, R. B., Daniels, S. R., Koren, M. J., Mever, R. A. and Faragh, J. U. (1995) Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk. J. Am. Coll. Cardiol. 25, 1056-1062
14. Takatsuji, H., Mikami, T., Urasawa, K. et al. (1996) A new approach for evaluation of left ventricular diastolic function: spatial and temporal analysis of left ventricular filling flow propagation by color M-mode Doppler echocardiography. J. Am. Coll. Cardiol. 27, 365-371
15. Palmieri, V., Innocenti, F., Pini, R. and Celentano, A. (2005) Reproducibility of Doppler echocardiographic assessment of left ventricular diastolic function in multicenter setting. J. Am. Soc. Echocardiogr. 18, 99-106
16. Nishimura, R. A. and Tajik, A. J. (1997) Evaluation of diastolic filling of left ventricle in health and disease: doppler echocardiography is the clinician's rosetta stone. J. Am. Coll. Cardiol. 30, 8-18
17. Andersen, N. H. and Poulsen, S. H. (2003) Evaluation of the longitudinal contraction of the left ventricle in normal subjects by Doppler tissue tracking and strain rate. J. Am. Soc. Echocardiogr. 16, 716-723
18. Anan, F., Takahashi, N., Ooie, T., Hara, M., Yoshimatsu, H. and Saikawa, T. (2004) Candesartan, an angiotensin II receptor blocker, improves left ventricular hypertrophy and insulin resistance. Metab., Clin. Exp. 53, 777-781
19. Vaitkevicius, P. V., Lane, M., Spurgeon, H. et al. (2001) A cross-link breaker has sustained effects on arterial and ventricular properties in older rhesus monkeys. Proc. Natl. Acad. Sci. U.S.A. 98, 1171-1175
20. Asif, M., Egan, J., Vasan, S. et al. (2000) An advanced glycation endproduct cross-link breaker can reverse age-related increases in myocardial stiffness. Proc. Natl. Acad. Sci. U.S.A. 97, 2809-2813
21. Flyvbjerg, A., Denner, L., Schrijvers, B. F. et al. (2004) Long-term renal effects of a neutralizing rage antibody in obese type 2 diabetic mice. Diabetes 53, 166-172
22. Belke, D. D., Larsen, T. S., Gibbs, E. M. and Severson, D. L. (2001) Glucose metabolism in perfused mouse hearts overexpressing human GLUT-4 glucose transporter. Am. J. Physiol. Endocrinol. Metab. 280, E420-E427
23. Frustaci, A., Kajstura, J., Chimenti, C. et al. (2000) Myocardial cell death in human diabetes. Circ. Res. 87, 1123-1132
24. de Simone, G., Kitzman, D. W., Palmieri, V. et al. (2004) Association of inappropriate left ventricular mass with systolic and diastolic dysfunction: the HyperGEN Study. Am. J. Hypertens. 17, 828-833
25. de Simone, G., Palmieri, V., Bella, J. N. et al. (2002) Association of left ventricular hypertrophy with metabolic risk factors: the HyperGEN Study. J. Hypertens. 20, 323-331
26. Liu, J. E., Robbins, D. C., Palmieri, V. et al. (2003) Association of albuminuria with systolic and diastolic left ventricular dysfunction in type 2 diabetes: the Strong Heart Study. J. Am. Coll. Cardiol. 41, 2022-2028
27. Cerasola, G., Cottone, S., Mule, G. et al. (1996) Microalbuminuria, renal dysfunction and cardiovascular complication in essential hypertension. J. Hypertens. 14, 915-920
28. Karalliedde, J. and Viberti, G. (2004) Microalbuminuria and Cardiovascular Risk. Am. J. Hypertens. 17, 986-993
29. Ronnback, M., Isomaa, B., Fagerudd, J. et al. (2006) Complex relationship between blood pressure and mortality in type 2 diabetic patients: a follow-up of the Botnia Study. Hypertension 47, 168-173
30. Sharman, J. E., Fang, Z. Y., Haluska, B., Stowasser, M., Prins, J. B. and Marwick, T. H. (2005) Left ventricular mass in patients with type 2 diabetes is independently associated with central but not peripheral pulse pressure. Diabetes Care 28, 937-939